Case Report
Published on 26 Oct 2022
Ropeginterferon-alfa2b resolves angina pectoris and reduces JAK2V617F in a patient with clonal hematopoiesis of indeterminate potential: A case report
in Hematopoiesis and Stem Cells
![Ropeginterferon-alfa2b resolves angina pectoris and reduces JAK2V617F in a patient with clonal hematopoiesis of indeterminate potential: A case report](https://www.frontiersin.org/files/myhome article library/1005666/1005666_Thumb_400.jpg)
Frontiers in Hematology
doi 10.3389/frhem.2022.1005666
- 956 views
- 1 citation